Clinical Trial WATCH |
Paternal Preconception Hepatitis B Virus Infection and Risk of Congenital Heart Disease in Offspring
Time to read: 0 minutes, 57 seconds.
Published on MedED: 22 August 2024
Source: JAMA Paediatrics
Date Originally Published: 19 August 2024
Type of article: Clinical Trial Watch
MedED Catalogue Reference: MPLCT011
Category: Paediatrics & Neonatology
Category Cross-reference: Infectious Diseases
Keywords: hepatitis B, congenital heart disease, maternal wellbeing, neonatal, paediatrics
Top
This summary is intended to provide a snapshot of the original research. It is in no way a substitute for the original research article, nor is it intended to be a complete reflection of the original research.
Originally published in JAMA Paediatrics,19 August 2024
Previous studies have linked maternal hepatitis B virus (HBV) infection with congenital heart diseases (CHDs) in offspring, but the association with paternal preconception HBV infection was less documented. This retrospective cohort study, utilising data from the Free Preconception Checkup Project (NFPCP) in mainland China, investigated this association.
Male participants, whose wives were aged 20 to 49 years and who were HBV-negative and had conceived within a year after their pre-pregnancy exam were enrolled in the study.
The primary exposure was paternal preconception HBV infection status—uninfected, previous infection, or new infection—while maternal HBV status was classified as immune or susceptible.
The researchers recorded that among the 30,047,924 couples enrolled:
• Paternal HBV infection was associated with a 40% increased risk of CHDs irrespective of maternal HBV immune status.
• The risk of CHDs in offspring was similar for previously HBV-infected husbands, whether wives were susceptible or immune.
• Offspring of couples with newly HBV-infected husbands and immune wives had a significantly higher risk, whereas no increased risk was found with immune susceptible wives.
• Maternal immune status did not interact with paternal HBV infection.
The findings highlight the need for personalised reproductive guidance, emphasising HBV screening and prevention for both partners.
Back to top
Disclaimer
This article is compiled from various resources researched and compiled by the contributor. It is in no way presented as an original work. Every effort has been made to attribute quotes and content correctly. Where possible, all information has been independently verified. The Medical Education Network bears no responsibility for any inaccuracies which may occur from the use of third-party sources. If you have any queries regarding this article contact us
Fact-checking Policy
The Medical Education Network makes every effort to review and fact-check the articles used as source material in our summaries and original material. We have strict guidelines in relation to the publications we use as our source data, favouring peer-reviewed research wherever possible. Every effort is made to ensure that the information contained here is an accurate reflection of the original material. Should you find inaccuracies, out of date content or have any additional issues with our articles, please make use of the contact us form to notify us.